What We Have Learned From The First-Stage Animal Safety Trial
EMF Disturbance Monitors, Inc. collaborated with the Biomedical Imaging Research Imaging Center at the University of North Carolina at Chapel Hill on March 20, 2024 for the first stage of our animal safety trial. A second stage of the animal safety trial is planned in April, 2024. We collected data for three days which our team has already begun to analyze. I want to assure all of our readers that the Rhesus macaque monkeys who were our study patients in the trial were treated well and in accordance with national standards. Both rejoined their colony later in the day.
Much of the data we collected involved verifying that our prototypes performed correctly. We tested the magnetic fields created by our electromagnets to assure the fields were stable and uniform. We tested our specialized electromagnetic sensors in various orientations and in the wearable, 3-dimensional vest. Reese, our stuffed Rhesus monkey, was tested in a variety of electromagnetic fields while wearing the vest. Reese was an outstanding patient and provided us with loads of data.
After verifying that our equipment was performing correctly, we tested our technology on two Rhesus macaque monkeys. Each monkey wore the sensor vest for 30 minutes while we obtained readings in a series of electromagnetic fields. This is the most important data we obtained during this stage of the trial.
Our company will not be reporting the results of the EMF disturbance technology data until we complete the second stage of the animal safety trial. What I can confirm is that the prototype equipment performed well. The electromagnetic fields created by the EMF generator were stable and uniform. The data from the pre-clinical portion of the trial confirmed Maxwell’s law, a law in physics that describes how the energy of an electromagnetic field diminishes with increasing frequency. The specialized sensors (MC95rW, Magnetic Sciences, Acton, MA, USA) were extremely sensitive and consistent. We confirmed that our data files from each test were logged correctly.
We are excited about the second stage of the animal safety trial. We have asked our engineers to make some minor upgrades to our software and hardware based on the initial results to improve our data capture and to narrow down the optimum frequency of the electromagnetic field for the detection of electromagnetic energy emissions of the heart. In May, I hope to share some of the exciting scientific data we obtained from our animal patients. Follow our journey on our Website, emfdisturbancemonitors.com and on Linkedin.com
